Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mónica Gayoso-Rey"'
Autor:
José Seijas-Amigo, Maria José Mauriz-Montero, Pedro Suarez-Artime, Mónica Gayoso-Rey, Francisco Reyes-Santías, Ana Estany-Gestal, Antonia Casas-Martínez, Lara González-Freire, Ana Rodriguez-Vazquez, Natalia Pérez-Rodriguez, Laura Villaverde-Piñeiro, Concepción Castro-Rubinos, Esther Espino-Paisán, Octavio Cordova-Arevalo, Diego Rodriguez-Penas, Begoña Cardeso-Paredes, Marta Ribeiro-Ferreiro, Moisés Rodríguez-Mañero, Alberto Cordero, José R. González-Juanatey, MEMOGAL Investigators
Publikováno v:
Diseases, Vol 12, Iss 10, p 244 (2024)
The primary objective of this study was to conduct a cost–utility analysis of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in real-world, comparing their use with standard care for managing cardiovascular disease. A multicenter
Externí odkaz:
https://doaj.org/article/5f7b5f76f0bb48bbbf874536a08de5ff
Publikováno v:
Pharmaceuticals, Vol 15, Iss 1, p 59 (2022)
The aim of this study was to evaluate the efficacy of a treat-and-extend (T&E) regimen of ranibizumab as the first-choice treatment in macular oedema (MO) secondary to branch retinal vein occlusion (BRVO). We conducted a retrospective study of 20 pat
Externí odkaz:
https://doaj.org/article/69e45dc0a02c4dc99990c377db672910
Autor:
Jose Seijas-Amigo, Mónica Gayoso-Rey, María José Mauriz-Montero, Pedro Suarez-Artime, Antonia Casas-Martinez, María Dominguez-Guerra, Lara Gonzalez-Freire, Ana Estany-Gestal, Alberto Codero-Fort, Moisés Rodriguez-Mañero, Jose Ramón Gonzalez-Juanatey
Publikováno v:
Clinica E Investigacion En Arteriosclerosis
Objetivos: El estudio MEMOGAL (NCT04319081) está dirigido a evaluar cambios en la función cognitiva en pacientes tratados con inhibidores de la PCSK9 (iPCSK9). Se realiza primer análisis: 1) Discutir el papel de los farmacéuticos hospitalarios du
Autor:
Jose M Pego-Reigosa, María Luísa De Castro-Parga, Daniel González-Vilas, Amelia Cibeira-Badia, María Guadalupe Piñeiro-Corrales, Nerea García-Beloso, Ángel Salgado-Barreira, Irene Altabás-González, Mónica Gayoso-Rey, Marisol Samartín-Ucha, Noemí Martínez-López de Castro
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(4)
Aims Adalimumab is a biological therapy used to treat different chronic inflammatory diseases. At present, there is an increasing number of adalimumab biosimilars. To assume the acceptability of interchangeability between reference adalimumab and bio
Autor:
Mónica Gayoso-Rey, Noemí Martínez-López de Castro, Adolfo Paradela-Carreiro, Marisol Samartín-Ucha, David Rodríguez-Lorenzo, Guadalupe Piñeiro-Corrales
Publikováno v:
Farmacia Hospitalaria, Vol 45, Iss 1, Pp 3-9 (2021)
The objective of this study was to assess the results of applying Lean Methodology in the design of a standardized medication storage model in hospitalization departments.Descriptive and retrospective study conducted between September 2017 and Januar
Autor:
Marisol Bravo-Amaro, Elena Yaiza Romero-Ventosa, Cristina Martínez-Reglero, Nerea García-Beloso, Pablo Fernández-Catalina, Olaia Díaz-Trastoy, Carlos Crespo-Diz, Regina Palmeiro-Carballeira, Beatriz Mantiñán-Gil, Mónica Gayoso-Rey, Karina Lorenzo-Lorenzo, Lara González-Freire, Guadalupe Piñeiro Corrales, María del Mar López-Gil-Otero
Publikováno v:
Clinical therapeutics. 43(4)
Purpose To evaluate the effectiveness, adverse reactions, and adherence to treatment of hypolipidemic inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9is) in a context of real clinical practice. Methods We present an observational, r
Autor:
Nerea, García-Beloso, Elena Yaiza, Romero-Ventosa, Mónica, Gayoso-Rey, Aida, López-López, David, Robles-Torres, Noemí Martínez-López, de Castro, Guadalupe, Piñeiro-Corrales
Publikováno v:
Journal of Cancer Research and Therapeutics. 18:367
Colorectal cancer is the ninth leading cause of death in Spain. The latest therapeutic developments in the advanced stages of this disease are the oral drugs trifluridine/tipiracil and regorafenib.Results of clinical trials (CTs) are not in real cond
Autor:
Pablo Lamas-Domínguez, Marisol Samartín-Ucha, Mónica Gayoso-Rey, Julio García-Comesaña, David Rodríguez-Lorenzo, Guadalupe Piñeiro-Corrales, Elena Yaiza Romero-Ventosa, Martín Rubianes-González, María Holanda Rodríguez-Vázquez
Publikováno v:
Therapeutic Innovation & Regulatory Science. 52:94-99
The care transition is the time when more medication errors occur. The aim of this study is to analyze the usefulness of a pharmacotherapeutic report model at hospital discharge to prevent medication errors and to simplify pharmacotherapy during a pa
Autor:
Laura Buján-de Gonzalo, Mónica Gayoso-Rey, María José Álvarez-Sánchez, Julio García-Comesaña, Elena Yaiza Romero-Ventosa, Guadalupe Piñeiro-Corrales, Belén Leboreiro-Enríquez
Publikováno v:
Therapeutic innovationregulatory science. 54(1)
Although the electronic prescribing software is the same for all hospitals of a regional health service, each has its own drug database, which it is responsible for maintaining. The aim of this study was to develop a consensus to standardize the hosp
Autor:
Marisol Samartín-Ucha, Miguel Fariña-Conde, Noemi Martínez-López-de-Castro, Guadalupe Piñeiro-Corrales, Cristina Casanova-Martínez, Alicia Martín-Vila, Mónica Gayoso-Rey, Miriam Álvarez-Payero, Débora Feijoo-Meléndez, Patricia Iglesias-Neiro
Publikováno v:
European journal of hospital pharmacy : science and practice. 25(4)
Objective To analyse the factors leading to greater satisfaction among patients attending the outpatient hospital pharmacy (OPh). Methods A cross-sectional study was conducted of patients attending the OPh of a 1250-bed university hospital. A self-ad